[Isolation and properties of highly purified C1. botulinum toxin type E]. 1979

G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova

A new method of isolation of highly purified Cl. botulinum toxin of E type from the cultural fluid of strain 188 centrifugates was developed. The method allows to isolate the toxin both in a precursor and in activated forms with a yield of 10--15%. The method includes fractionation by ammonium sulfate, ultrafiltration and subsequent column chromatography on DEAE-cellulose, Sephadex G-200 and DEAE-Sephadex A-50. The preparations were found homogeneous during polyacrylamide gel electrophoresis and immunoprecipitation in agar with antitoxic horse serum. The potential specific toxicity of the preparations is 1--1,2.10(7) DLM/mg of protein. The molecular weight of the toxin is about 160 000; the molar extinction coefficient is equal to 278 nm. The isoelectric point lies around pH 6.0. The highly purified Cl. botulinum toxin of E type was found stable upon storage.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D003014 Clostridium botulinum A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes (sometimes called antigenic types, or strains) exist, each producing a different botulinum toxin (BOTULINUM TOXINS). The organism and its spores are widely distributed in nature.
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
November 1980, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
December 1990, Japanese journal of medical science & biology,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
April 1975, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
January 1968, Medycyna doswiadczalna i mikrobiologia,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
October 1968, Biochimica et biophysica acta,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
July 1986, Journal of general microbiology,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
March 1968, Nihon saikingaku zasshi. Japanese journal of bacteriology,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
October 1954, Canadian journal of microbiology,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
November 1947, Journal of bacteriology,
G A Levdikova, and L V Klimacheva, and M V Ispolatovskaia, and T I Bulatova, and L I Anisimova
March 1967, Applied microbiology,
Copied contents to your clipboard!